House committee substitute to the 2nd edition amends the GS 14-313.1 definition of hemp-derived consumable product as a hemp product that is a finished good intended for human ingestion or inhalation that contains a concentration of any hemp-derived cannabinoid, so that it now includes any hemp product that at the time of sale to the ultimate consumer contains a delta-9 THC concentrate of not more than .3 on a dry weight basis.